# US 2026/0086058 A1 · Impedance-based assessment of blood samples > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 2026/0086058 A1 - Document ID: US20260086058A1 - Status: Published application - Kind: A1 - Application number: 19/337,302 - Filed: 2025-09-23 - Published: 2026-03-26 - Earliest claimed: 2024-09-24 - Applicants: Case Western Reserve University; Emory University - Inventors: Pedram Mohseni; Umut A. Gurkan; Michael A. Suster; Vivien A. Sheehan; Solomon Oshabaheebwa; Christopher A. Delianides; Akshay A. Patwardhan - Web page: https://patentgrep.com/patent/US20260086058A1 ## CPC - G01N 27/028: {Circuits therefor (measuring impedance per se G01R27/02)} - G01N 33/49: Blood {(chemical methods for determining blood cell populations G01N33/5094; chemical analysis of blood groups or blood types G01N33/80)} - G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q) ## Abstract A described example relates to a system that includes a microfluidic device and an impedance analyzer. The microfluidic device includes a microchannel extending through a portion of a housing. The microchannel is configured to receive a fluid sample including blood cells that flows along in a direction of fluid flow through the microchannel. The microchannel includes a plurality of micropillar arrays along the direction of fluid flow, and each of the plurality of micropillar arrays is located between a respective pair of electrodes in the microchannel. The impedance analyzer can be coupled to each of the electrodes and configured to measure electrical impedance of at least some of the micropillar arrays at multiple times, in a wash-free assay, including at least one impedance measurement before the fluid sample is flowing through the microchannel and at least one impedance measurement after the fluid sample is flowing through the microchannel. ## Claims ### Claim 1 A system for wash-free electrical impedance-based assessment of blood cell properties comprising: a microfluidic device that includes a microchannel extending through a portion of a housing, the microchannel being configured to receive a fluid sample including blood cells that flows along in a direction of fluid flow through the microchannel, the microchannel including a plurality of micropillar arrays along the direction of fluid flow, and each of the plurality of micropillar arrays being located between a respective pair of electrodes in the microchannel; and an impedance analyzer coupled to each of the electrodes and configured to measure electrical impedance of at least some of the micropillar arrays at multiple times, in a wash-free assay, including at least one impedance measurement before the fluid sample is flowing through the microchannel and at least one impedance measurement after the fluid sample is flowing through the microchannel. ### Claim 2 (depends on 1) The system of claim 1, wherein the impedance analyzer comprises: a signal generator configured to generate an excitation signal; a switch network configured to route the excitation signal to a selected electrode of a given pair of the electrodes to pass the excitation signal through a respective one of the micropillar arrays to another electrode of the given pair of electrodes and provide a corresponding signal to an output of the switch network; and an amplifier configured to provide an output signal responsive to the corresponding signal, wherein the impedance analyzer is configured to determine the measure of electrical impedance based on the excitation signal and the output signal. ### Claim 3 (depends on 2) The system of claim 2, wherein the switch network comprises: a demultiplexer having an input and a plurality of outputs, wherein the input of the demultiplexer is coupled to an output of the signal generator to receive the excitation signal, the plurality of outputs is coupled to an input electrode of each respective pair of the electrodes, and the demultiplexer is configured to route the excitation signal to the input electrode of each respective pair of the electrodes responsive to a first selection signal; and a multiplexer having a plurality of inputs and an output, wherein each of the plurality of inputs of the multiplexer is coupled to an output electrode of each respective pair of the electrodes, the output of the multiplexer is coupled to an input of the amplifier, and the multiplexer is configured to route the corresponding signal from a selected one of the plurality of inputs to the output of the multiplexer responsive to a second selection signal. ### Claim 4 (depends on 3) The system of claim 3, wherein the impedance analyzer comprises: a processor configured to provide the first selection signal and the second selection signal to coordinate operation of the demultiplexer and the multiplexer in a time-multiplexed sequence such that the excitation signal is permitted to flow through a single pair of the electrodes and one of the micropillar arrays at a time. ### Claim 5 (depends on 2) The system of claim 2, wherein the amplifier comprises a transimpedance amplifier. ### Claim 6 (depends on 1) The system of claim 1, wherein the fluid sample includes red blood cells, and the impedance analyzer further comprises: a processor configured to determine a normalized impedance change for the at least some of the micropillar arrays based on the impedance measurements for each of the at least some of the micropillar arrays before and after the fluid sample is flowing through the microchannel. ### Claim 7 (depends on 6) The system of claim 6, wherein the processor is further configured to: estimate a normalized impedance contribution caused by free non-occluding red blood cells present in the microchannel; and subtract the normalized impedance contribution from the normalized impedance change determined for each of the at least some of the micropillar arrays to provide a corresponding compensated normalized impedance change for each of the at least some of the micropillar arrays. ### Claim 8 (depends on 7) The system of claim 7, wherein the processor is further configured to determine an assessment of deformability and/or microcapillary occlusion of the red blood cells in the fluid sample based on the compensated normalized impedance change for the at least some of the micropillar arrays. ### Claim 9 (depends on 8) The system of claim 8, wherein the processor is configured to calculate an index indicative of the assessment of deformability and/or microcapillary occlusion of the red blood cells in the fluid sample based on the normalized impedance change determined for the at least some of the micropillar arrays. ### Claim 10 (depends on 9) The system of claim 9, wherein the index defines an occlusion index (OI) for the red blood cells in the fluid sample, and the processor is configured to calculate the OI according to the following equation: OI = ( Z 1 - Z j ) · N 1 + ( Z 2 - Z j ) · N 2 + … + ( Z m - Z j ) · N m N 1 + N 2 ⁢ … + N m where : Z n = Z n , RBC Z n , baseline Zn represents the normalized impedance change determined for an nth micropillar array, where n and j are positive integers from 1 to m, and m+1 represents a total number of the micropillar arrays in the microchannel, Nn represents a total number of openings in the nth micropillar array, Zn,baseline represents a baseline impedance of the nth micropillar array measured before the fluid sample enters the microchannel, and Zn,RBC represents the impedance of the nth micropillar array measured after the fluid sample is flowing through each of the plurality of micropillar arrays of the microchannel. ### Claim 11 (depends on 1) The system of claim 1, wherein the fluid sample includes a therapeutic agent to modulate blood cell adhesion and/or deformability. ### Claim 12 A method comprising: perfusing a fluid sample including red blood cells into at least one microchannel of a microfluidic device, wherein the at least one microchannel includes a plurality of micropillar arrays arranged in a direction of fluid flow through the at least one microchannel, and each of the plurality of micropillar arrays is located between a respective electrode pair; measuring an electrical impedance of at least one micropillar array between a respective electrode pair including at least one measurement before the fluid sample has entered the microchannel and at least one measurement after the fluid sample has entered the microchannel, wherein the perfusion of the fluid sample and the measuring of electrical impedance are performed in the absence of washing of the microchannel; determining a normalized impedance change for the at least one micropillar array based on the measurements of the electrical impedance; and determining an assessment of deformability and/or microcapillary occlusion of the red blood cells in the fluid sample based on the normalized impedance change determined for the at least one micropillar array. ### Claim 13 (depends on 12) The method of claim 12, wherein the plurality of micropillar arrays are arranged in a direction of fluid flow through the microchannel, each of the plurality of micropillar arrays having progressively narrower micropillar openings in the direction of fluid flow, wherein the electrical impedance is measured for at least some of the micropillar arrays at times that include before and after the fluid sample has entered the microchannel, wherein normalized impedance changes are determined for the at least some of the micropillar arrays based on the electrical impedance measured between the respective electrode pairs, and wherein the assessment of deformability and/or microcapillary occlusion is determined based on the normalized impedance changes determined for the at least some of the micropillar arrays. ### Claim 14 (depends on 12) The method of claim 12, wherein measuring the electrical impedance of the at least one micropillar array comprises: measuring a first impedance of the at least one micropillar array before the fluid sample has entered the at least one micropillar array, wherein the first impedance defines a baseline impedance measurement; and measuring a second impedance of the at least one micropillar array after the fluid sample has entered the at least one micropillar array for at least a predetermined period of time, wherein the normalized impedance change is determined for the at least one micropillar array based on the first impedance and the second impedance. ### Claim 15 (depends on 12) The method of claim 12, wherein measuring the electrical impedance comprises: applying an excitation signal to a first electrode of the respective electrode pair for a given one of the micropillar arrays during a measurement interval; receiving an output signal at a second electrode of the respective electrode pair for the given one of the micropillar arrays responsive to the excitation signal during the measurement interval; and determining the measurements of the electrical impedance for the given one of the micropillar arrays based on the excitation signal and the output signal. ### Claim 16 (depends on 12) The method of claim 12, wherein the plurality of micropillar arrays comprises a first micropillar array and a second micropillar array within the microchannel located adjacent to each other along a direction of fluid flow through the microchannel, the first micropillar array is located between a first electrode and a second electrode, defining a first electrode pair, and the second micropillar array is located between the second electrode and a third electrode, defining a second electrode pair, the method further comprising: successively routing an excitation signal through the first electrode pair and the first micropillar array and through the second electrode pair and the second micropillar array during a first measurement interval before the fluid sample is flowing through the microchannel; successively routing the excitation signal through the first electrode pair and the first micropillar array and through the second electrode pair and the second micropillar array during a second measurement interval after the fluid sample is flowing through the microchannel; determining a normalized impedance change for the first micropillar array based on electrical impedances measured between the first electrode pair during the first and second measurement intervals; and determining a normalized impedance change for the second micropillar array based on electrical impedances measured between the second electrode pair during the first and second measurement intervals. ### Claim 17 (depends on 12) The method of claim 12, wherein determining the assessment of deformability and/or microcapillary occlusion further comprises: estimating a normalized impedance contribution caused by free non-occluding red blood cells present in the microchannel; and subtracting the normalized impedance contribution from the normalized impedance change determined for the at least one micropillar array to provide a compensated normalized impedance change for the at least one micropillar array, wherein the assessment of deformability and/or microcapillary occlusion of the red blood cells in the fluid sample is determined based on the compensated normalized impedance change. ### Claim 18 (depends on 12) The method of claim 12, wherein the electrical impedance is measured for each of the micropillar arrays between a respective electrode pair, wherein the electrical impedance measurements for each of the micropillar arrays include at least one measurement before the fluid sample is flowing through the microchannel and at least one measurement after the fluid sample is flowing through the microchannel, wherein normalized impedance changes are determined for each of the micropillar arrays based on the electrical impedance measurements for each of the respective micropillar arrays before and after the fluid sample is flowing through the microchannel, and wherein the assessment of deformability and/or microcapillary occlusion of the red blood cells in the fluid sample is determined based on the normalized impedance changes determined for each of the respective micropillar arrays. ### Claim 19 (depends on 18) The method of claim 18, wherein the assessment of deformability and/or microcapillary occlusion is determined as an occlusion index (OI) for the red blood cells in the fluid sample, and the OI is calculated according to the following equation: OI = ( Z 1 - Z j ) · N 1 + ( Z 2 - Z j ) · N 2 + … + ( Z m - Z j ) · N m N 1 + N 2 ⁢ … + N m where : Z n = Z n , RBC Z n , baseline Zn represents the normalized impedance change determined for an nth micropillar array, where n and j are positive integers from 1 to m, and m+1 represents a total number of the micropillar arrays in the microchannel, Nn represents a total number of openings in the nth micropillar array, Zn,baseline represents a baseline impedance of the nth micropillar array measured before the fluid sample enters the microchannel, and Zn,RBC represents the impedance of the nth micropillar array measured after the fluid sample is flowing through each of the plurality of micropillar arrays of the microchannel. ### Claim 20 (depends on 12) The method of claim 12, wherein the fluid sample includes a therapeutic agent to modulate red blood cell adhesion and/or deformability. ### Claim 21 A method of measuring efficacy of a therapeutic agent in modulating red blood cell adhesion and/or deformability, the method comprising: perfusing a fluid sample including red blood cells through at least one microchannel of a microfluidic device, wherein the at least one microchannel includes a plurality of micropillar arrays arranged in a direction of fluid flow through the at least one microchannel, and each of the plurality of micropillar arrays is located between a respective pair of electrodes; measuring an electrical impedance of at least one micropillar array in the at least one microchannel before and after perfusion of the fluid sample through the at least one microchannel, wherein the perfusion of the fluid sample and the measuring of the electrical impedance are performed wash-free; determining a normalized impedance change for the at least one micropillar array based on the electrical impedance measured before and after the fluid sample is being perfused through the microchannel; and determining the measure of efficacy of the therapeutic agent based on a comparison of the normalized impedance change for the at least one micropillar array to a control. ### Claim 22 (depends on 21) The method of claim 21, wherein the therapeutic agent is added to the fluid sample that is perfused through the at least one microchannel, and/or wherein the fluid sample is obtained from a subject having the therapeutic agent administered in vivo. ### Claim 23 (depends on 21) The method of claim 21, further comprising: adjusting the normalized impedance change for the at least one micropillar array to compensate for a normalized impedance contribution caused by free non-occluding red blood cells present in the microchannel; and calculating an occlusion index (OI) based on the adjusted normalized impedance change for the at least one micropillar array, wherein the OI is representative of an assessment of deformability and/or microcapillary occlusion of the red blood cells in the fluid sample responsive to the therapeutic agent that has been added, and the measure of efficacy is determined based on a comparison of the OI to a control index, wherein the control index is determined for a fluid sample having a different amount of the therapeutic agent or without the therapeutic agent.